Main Article Content
Background: With the increasing education on breast cancer, most women are reporting to the hospital with breast lumps most of which are benign breast lesions. Benign breast diseases constitute a heterogeneous group of lesions including developmental abnormalities, inflammatory lesions, epithelial and stromal proliferation and neoplasms. This is to look at the various histologic type of benign proliferative breast diseases among Ghanaian women.
Methods: This is a retrospective study of breast excisions received between 2006-2013 at the Department of Pathology, Korle Bu teaching hospital (KBTH), Ghana. All histological slides were retrieved and examine. Demographic information was also retrieved from the request form. The data was subject to analysis using SPSS version 16.5 and Windows Excel.
Results: During the period of study, 2,805 cases of benign breast lesions were received by the department, out of which 2,396 were proliferative benign lesions representing 89.4%. The top five lesions were fibroadenoma (89.01%), fibroadenomatoid hyperplasia (3.26%), tubular adenoma (2.51%), benign phylloides tumour (1.71%) and intraductal papilloma (1.59%). The average ages of clients with these lesions were 24 years (±8.3 years), 28 years (±10.7 years), 22.7 years (±15 years), 38 years (±14.2 years and 45.4 years (±8.3 years) respectively. Fibroadenoma and benign phelloides tumour have a preponderance to the right and left breast respectively with statistical significance.
Conclusion: There are some differences between benign breast lesions in Ghanaian women as compared to other African countries within the Sub Saharan region.
Eric Gyan, Leonard Derkyi-Kwarteng, Ato Ampomah Brown, Abigail Derkyi-Kwarteng, Abrahams Afua Darkwa, Solomon Quayson, Patrick Kafui Akakpo Benign breast conditions: An eight-year single-centred histopathologic review of women presenting with mass lesions at the Korle-Bu Teaching Hospital, Ghana. Annals of Diagnostic Pathology. 2019;42: 33-38.
Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. The Oncologist. 2006;11: 435–449.
American Cancer Society.
Available:http://www.cancer.org/acs/groups/cid/documents/webcontent/003180-pdf.pdf.last reviewed 2016.
(Accessed in December, 2016)
Bonewit-WestKathy, Sue Huntand Edith Applegate. Today's medical assistant: Clinical and administrative procedures. Elsevier Health Sciences. 2015;419.
Fortugno LP. Frontiers in Breast Cancer Research. Nova Publishers. 2007;1.
Edward T. Bope Rick D. Kellerman. Conn's current therapy. Elsevier Health Sciences. 2015;1025.
Chinyama CN. Benign breast diseases: Radiology - pathology - risk assessment, 2nd edition. Springer Science & Business Media. 2013;9.
Pearlman MD, Griffin JL. Benign breast disease. Obstet Gynecol. 2010;116(3): 747-58.
Okoth Christopher, Moses Galukande Josephat Jombwe, Dan Wamala. Benign proliferative breast diseases among female patients at a sub Saharan Africa tertiary hospital: A cross sectional study. BMC Surgery. 2013;13:9.
Olu-Eddo AN, Ezekiel Enoghama Ugiagbe. Benign breast lesions in an African population: A 25-year histopathological review of 1864 cases. Niger Med J. 2011;52(4):211–216.
Oheneba – Yeboah M, Amaning EP. Spectrum of complaints presented at specialist breast clinic in Kumasi, Ghana. Ghana Medical Journal. 2008;11(3):110-112.
Uwaezuoke Stanley Chibuzo, Ezenwa Patrick Udoye. Benign breast lesions in Bayelsa State, Niger Delta Nigeria: A 5 year multicentre histopathological audit. The Pan African Medical Journal. 2014;19: 394.
Dupoint WD, Parl FF, Hartmann WH, Winfield AC, Worrel JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 2006;71:1258-65.
Betraw C. fibroadenoma in women in Ghana. Pan Afri Med J. 2009;2:11.
Irabor DO, Okolo CA. An audit of 149 conservative breast biopsies in Ibadan, Nigeria. Pak J Med Sci. 2008;24:257-62.
Ochicha O, Edino ST, Mohammed AZ, Amin SN. Benign breast lesions in Kano. The Nigerian Journal of Surgical Research. 2002;4(1):1-5.